Home Business Larimar Therapeutics president and CEO Carole Ben-Maimon acquires $49,953 in stock
Business

Larimar Therapeutics president and CEO Carole Ben-Maimon acquires $49,953 in stock

Share
Larimar Therapeutics president and CEO Carole Ben-Maimon acquires ,953 in stock
Share


Larimar Therapeutics president and CEO Carole Ben-Maimon acquires $49,953 in stock

Source link

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep in touch

Subscribe to our newsletter to get our newest articles instantly!

    Copyright 2025. All rights reserved